Amerise Biosciences Limited (BOM:531681)
India flag India · Delayed Price · Currency is INR
0.7600
-0.0500 (-6.17%)
At close: Jul 22, 2025

Amerise Biosciences Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Jul '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
5060444690109
Upgrade
Market Cap Growth
37.88%37.88%-5.71%-48.53%-17.58%101.22%
Upgrade
Enterprise Value
5060454690121
Upgrade
Last Close Price
0.760.910.660.701.361.65
Upgrade
PE Ratio
880.921054.79--16.36-
Upgrade
PS Ratio
26.7131.98121.46525.550.94-64.52
Upgrade
PB Ratio
0.931.120.810.841.592.14
Upgrade
P/TBV Ratio
0.931.120.810.841.592.14
Upgrade
P/OCF Ratio
1.641.96--146.34-
Upgrade
EV/Sales Ratio
26.5931.90124.09524.950.94-
Upgrade
EV/EBIT Ratio
-799.52--16.32-
Upgrade
Debt / Equity Ratio
---0.020.02-
Upgrade
Asset Turnover
0.030.030.010.001.09-
Upgrade
Quick Ratio
0.010.011.360.370.990.04
Upgrade
Current Ratio
0.010.011.480.370.990.04
Upgrade
Return on Equity (ROE)
0.11%0.11%-2.68%-2.13%10.24%-6.41%
Upgrade
Return on Assets (ROA)
0.07%0.07%-1.65%-1.18%3.90%-3.62%
Upgrade
Return on Capital (ROIC)
0.09%0.09%-1.66%-1.83%6.35%-4.01%
Upgrade
Return on Capital Employed (ROCE)
0.10%0.10%--9.60%-
Upgrade
Earnings Yield
0.11%0.10%-3.35%-2.57%6.11%-3.09%
Upgrade
Buyback Yield / Dilution
19.86%19.86%----
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.